PMID: 6105675Jun 1, 1980Paper

Selective permeation of the blood-brain barrier as a cause of the anomalous properties of 'atypical'neuroleptics

Pharmacology, Biochemistry, and Behavior
L J Herberg, T B Wishart

Abstract

Metoclopramide is a widely used anti-emetic drug with potent dopamine-blocking effects on brain structures involved in emesis and prolactin secretion but it is apparently devoid of therapeutic effect in schizophrenia, thus calling into question the supposed role of dopamine blockade in the action of antischizophrenic drugs. This investigation compared the depression of hypothalamic self-stimulation produced by metoclopramide and by a 'typical' neuroleptic, spiroperidol (spiperone), when injected by different routes. Metoclopramide was found to9 be nearly 30 times more potent when administered directly into the brain via the cerebral ventricles than when injected intraperitoneally; on the other hand the potency of spiroperidol was virtually unaffected by the route of administration. The blood-brain barrier is known to be absent from brain sites controlling emesis and prolactin secretion; thus the potency of metoclopramide as an anti-emetic and in releasing prolactin, and its relative ineffectiveness as an antipsychotic can be accounted for by a failure to enter the brain freely except at privileged sites. Thus its anomalous properties are not necessarily inconsistent with the dopamine theory of schizophrenia.

References

Jan 1, 1978·The Journal of Pharmacy and Pharmacology·P JennerC D Marsden
May 1, 1975·Neuropharmacology·A MangoniG L Gessa
Jan 1, 1973·Psychopharmacologia·W C Stern, P J Morgane
Dec 1, 1954·Journal of Comparative and Physiological Psychology·J OLDS, P MILNER

❮ Previous
Next ❯

Citations

Apr 23, 1982·European Journal of Pharmacology·S BischoffR Ortmann
Jan 1, 1982·Pharmacology & Therapeutics·N Bodor, M E Brewster
Oct 29, 2015·Journal of Neurogastroenterology and Motility·Hironobu MikamiYoshikazu Kinoshita
Feb 1, 1989·The Journal of Pharmacy and Pharmacology·J K ChiversC D Marsden
Jan 1, 1992·Neuroscience and Biobehavioral Reviews·G J Schaefer, R P Michael

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here